National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 1 of 2002) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 1 of 2002

I, JAMES McLAREN FOX, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

1. This Declaration commences on 1 February 2002.

1. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

“Aminogran Mineral Mixture”

Oestradiol Valerate and Oestradiol Valerate with Medroxyprogesterone Acetate

Red-back Spider Antivenom

Streptokinase

Dated this 8^th day of January 2002.

JAMES McLAREN FOX

Acting Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health and Ageing

Delegate of the Minister for Health and Ageing